FDA Investigator

Timothy Kamaldinov

Latest inspection on record: Portsmouth, United States, June 2025 · records back to 2024

Biologics

FDA inspection record · Last updated July 12, 2026

Overview

  • 5 inspections across 5 sites are on record.
  • 0 Form 483 observations are attributed to this investigator.
  • Most recent recorded activity is 2025-06-06.

At a glance

Inspections

5

Sites

5

Observations

0

Career since

Jul 2024

Recent inspections

Most recent inspections in the published record.

SiteDateCategoryForm 483
Lonza Biologics, Inc.6 Jun 2025BiologicsOn file
ULTRAGENYX30 Apr 2025BiologicsOn file
ULTRAGENYX25 Apr 2025BiologicsOn file
WX ATU Co., Ltd.12 Mar 2025BiologicsOn file
Lonza Netherlands B.V.12 Jul 2024BiologicsOn file

Sites inspected

Lonza Biologics, Inc.Portsmouth, United States1 insp.
ULTRAGENYXWoburn, United States1 insp.
ULTRAGENYXBedford, United States1 insp.
WX ATU Co., Ltd.Wuxi, China1 insp.
Lonza Netherlands B.V.Geleen, Netherlands1 insp.

Co-investigators

Investigators who share inspections with this person.

Kula N Jha2 shared
Athena L Russell1 shared
Kinjal S Patel1 shared
Viviana R Ramirez1 shared
Xiuju Lu1 shared
Carl A Perez1 shared
Jie He1 shared
Graeme E Price1 shared

Full investigator report

Get the verbatim findings behind Timothy Kamaldinov's inspection record

Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.

  • New inspections and Form 483s, mapped to the CFR citation
  • Warning letter outcomes, and the citation patterns they repeat
  • Their co-investigators, so no surprises about who shows up on site

Related investigators